Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
Holding CNMD?
Track your performance easily
CNMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$61.05 - $117.27
Previous Close$75.35
Volume193.65K
Average Volume (3M)417.69K
Market Cap
$2.31B
Enterprise Value$3.29B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$965.89M
Price to Earnings (P/E)24.0
Beta1.15
Next Earnings
Oct 23, 2024EPS Estimate
$0.99Last Dividend Ex-Date
Sep 16, 2024Dividend Yield1.05%
Share Statistics
EPS (TTM)3.14
Shares Outstanding30,829,285
10 Day Avg. Volume375,128
30 Day Avg. Volume417,695
Standard Deviation0.11
R-Squared0.45
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.63
Price to Sales (P/S)1.84
Price to Cash Flow (P/CF)13.50
P/FCF Ratio12.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.58
Enterprise Value/Gross Profit4.86
Enterprise Value/Ebitda13.78
Forecast
1Y Price Target
$78.80Price Target Upside4.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Conmed News
PremiumCompany Announcements
Conmed Announces High-Level Executive Departure and Changes
PremiumCompany Announcements
Conmed Announces Executive Transition and New Officer Compensation
PremiumCompany Announcements
Conmed Announces Executive Leadership Changes and Compensation UpdatesBulls Say, Bears Say
Bulls Say
Financial PerformanceGross margin was up 90 bps year-over-year and operating margin was up 140 bps year-over-year.
Market PositionManagement views any market share loss as a result of the supply chain impact as being on the fringes and not impacting CNMD's long-term outlook.
Product DifferentiationManagement noted that insufflation at low pressure remains a key differentiator of AirSeal and longer, more complex procedures benefit from AirSeal.
Bears Say
EarningsManagement lowered their revenue and EPS guidance due to their expectation that the Orthopedics Surgery supply chain issues carry into 2H24.
Financial PerformanceGM improvement story intact, but 60% GM by the end of 2025 unlikely.
Revenue GrowthOrganic revenue growth slowed to 5.2% Y/Y in 2Q24 from 5.9% in 1Q24 as CNMD continued to have supply chain challenges in its Orthopedic Surgery business.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CNMD FAQ
What was Conmed’s price range in the past 12 months?
Conmed lowest stock price was $61.05 and its highest was $117.27 in the past 12 months.
What is Conmed’s market cap?
Currently, no data Available
When is Conmed’s upcoming earnings report date?
Conmed’s upcoming earnings report date is Oct 23, 2024 which is in 33 days.
How were Conmed’s earnings last quarter?
Conmed released its earnings results on Jul 31, 2024. The company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.07.
Is Conmed overvalued?
According to Wall Street analysts Conmed’s price is currently Undervalued.
Does Conmed pay dividends?
Conmed pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 1.05%. See more information on Conmed dividends here
What is Conmed’s EPS estimate?
Conmed’s EPS estimate is $0.99.
How many shares outstanding does Conmed have?
Conmed has 30,829,285 shares outstanding.
What happened to Conmed’s price movement after its last earnings report?
Conmed reported an EPS of $0.98 in its last earnings report, beating expectations of $0.91. Following the earnings report the stock price went down -5.359%.
Which hedge fund is a major shareholder of Conmed?
Among the largest hedge funds holding Conmed’s share is Deerfield Management Company, LP. It holds Conmed’s shares valued at 44M.
---
Conmed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$78.80 (4.97% Upside)
$78.80 (4.97% Upside)
Blogger Sentiment
Bullish
CNMD Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 277.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.07%
12-Months-Change
Fundamentals
Return on Equity
11.86%
Trailing 12-Months
Asset Growth
-1.60%
Trailing 12-Months
Company Description
Conmed
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its product lines also include orthopedic surgey and general surgery. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Utica, NY.
---
CNMD Company Deck
---
CNMD Earnings Call
Q2 2024
0:00 / 0:00
---
CNMD Stock 12 Month Forecast
Average Price Target
$78.80
▲(4.97% Upside)
Technical Analysis
Best Analysts Covering CNMD
1 Year
1 Year Success Rate
9/18 ratings generated profit
1 Year Average Return
+11.37%
reiterated a buy rating 2 months ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.37% per trade.
---